YZi Labs, a major shareholder of CEA Industries (BNC), expressed disappointment with the company's board's "poison pill" strategy and bylaw amendments in response to its written consent solicitation process. YZi Labs believes these actions are designed to thwart and delay shareholders' ability to exercise their rights through written consent, aiming to consolidate the board's position rather than protect shareholder interests. YZi Labs noted that the BNC board has postponed its 2025 annual meeting, originally scheduled for December 17th, and called on the board to avoid further manipulation and ensure a fair nomination and election process. Furthermore, YZi Labs refuted BNC's claim that it had never considered an alternative token strategy, stating that BNC CEO David Namdar explicitly stated at a November 2025 meeting that switching to assets such as Solana had been considered. YZi Labs has submitted a preliminary consent statement to the SEC, intending to expand the BNC board and elect its nominated board candidates. The participants in this solicitation include YZi Labs Management, Binance founder Changpeng Zhao, Max Baucus Sieben, David James Chapman, Marie Teresa Goody Guillené, Jiajin He, Alex Odagiu, Matthew Roszak, and Ling Zhang. Currently, YZi Labs Management directly holds 2,150,481 shares of BNC common stock.